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Abstract: 
The small intestine is composed of crypts that house intestinal stem cells (ISCs), which 
self-renew and differentiate to maintain the intestinal epithelium. Alternatively, intestinal villi 
contain absorptive enterocytes and secretory cells- goblet, enteroendocrine (EECs), tuft, and 
Paneth cells- that are derived from ISCs and maintain the gut's digestive and barrier functions. 
Chromatin is considered a major epigenetic component of cell identity and fate decision in 
embryonic and hematopoietic stem cell systems (Lara-Astiaso et al. 2014; Xie et al. 2013). 
However, the genetic and epigenetic mechanisms regulating ISC function remain poorly 
characterized. To better understand ISC regulation, we focused on Tet1, a chromatin modifying 
enzyme. Previous studies demonstrate Tet1 is essential for proper differentiation in embryonic 
stem cells and a tumor suppressor of hematopoietic malignancy, but Tet1’s role in the small 
intestine remains unknown (Ito et al. 2010; Cimmino et al. 2015). We hypothesized that Tet1 
establishes distinct gene regulatory networks in ISCs to promote differentiation and repress 
proliferation. To avoid lethality and developmental defects on adult mice, we used a Tet1 inducible 
knockout mouse model (Tet1iKO) that provides specificity to ISCs. Through immunofluorescence 
staining, we quantified tuft, EECs, ISCs, proliferating, and S-phase cells in each mouse. 
Fluorescence and confocal microscopy revealed that Tet1iKO mice contained fewer tuft cells and 
EECs than the control mice, suggesting Tet1 drives ISC differentiation for tuft cell and EEC 
lineages. Additionally, the Tet1iKO mice contained more ISCs than the control mice. However, 
there was no significant change in the number of proliferating cells between the two groups of 
mice. Our results suggest Tet1 promotes ISC differentiation but does not affect ISC proliferation 
rates. Delineating the role of Tet1 in the establishment of specific ISC states will further our 
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understanding of a Tet1-mediated ISC regulation pathway with applications to questions on 
intestinal damage and regeneration for digestive diseases. 
Introduction: 
The intestinal epithelium contains repeating crypt-villus units to maximize surface area for 
nutrient absorption. The crypt houses intestinal stem cells (ISCs), which self-renew and 
differentiate into post-mitotic specialized epithelial cells. The villus contains two subdivisions of 
specialized cell lineages derived from ISCs. The first are absorptive enterocytes. The second are 
secretory lineages, including antimicrobial-producing Paneth cells, mucus-producing goblet cells, 
and hormone-secreting enteroendocrine cells (EECs). Tuft cells represent a less characterized 
lineage but initiate immune response to parasitic infections in the intestine. When functioning 
correctly, ISCs differentiate and replace the epithelial cells in the villi every seven days (Gracz et 
al. 2014). Certain post-mitotic ISC lineages can undo differentiation and revert to a multipotent 
stem cell state, prompting questions on cell fate regulation in the small intestine (Tian et al. 2011; 
Yu et al. 2018).  
In the past, epigenetic regulation and chromatin structure was widely studied in cell lines, 
embryonic stem cells, and whole tissue. Current advances in sequencing technology allows us to 
explore these fields in the context of endogenous ISC biology. Previous studies reveal chromatin 
is a critical epigenetic component of cell identity and fate decisions in embryonic and 
hematopoietic stem cell systems (Lara-Astiaso et al. 2014; Xie et al. 2013). However, the role of 
chromatin in ISC differentiation and proliferation has not been established. To better understand 
the regulation of these ISC populations, we focused on chromatin-modifying enzymes. There are 
three ten-eleven translocation (TET) methylcytosine dioxygenase enzymes (Tet1, Tet2, Tet3), 
largely associated with increasing gene expression through DNA demethylation. TET enzymes 
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oxidize 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC), resulting in a stable 5hmC 
or reversion to a non-methylated cytosine (Wu et al. 2017). Additionally, TET1 can co-recruit 
other chromatin-modifying proteins such as PRC2 and HDACs to alter gene expression in a 
catalytically independent manner (Williams et al. 2011; Wu et al. 2011). For this study, we focused 
primarily on Tet1 because it is highly expressed in ISCs, while Tet2 and Tet3 are expressed in all 
intestinal epithelial cells (Kim et al. 2016). Earlier research on Tet1 function reveals its role in 
proper embryonic stem cell differentiation (Ito et al. 2010). Moreover, previous studies on 
hematopoietic malignancy and colon cancer cell lines suggest a tumor suppressive role for Tet1 
through the regulation of WNT-inhibitory genes (Cimmino et al. 2015; Neri et al. 2015). 
Nonetheless, Tet1’s role in chromatin regulation for ISCs remains poorly characterized.   
To determine if Tet1 regulates ISC fate, we knocked out Tet1 in the intestine of adult mice 
for enough time to see full cell turn over. While selecting a Tet1 knockout mouse model, we 
preferred to avoid lethality (Kang et al. 2015; Khoueiry et al. 2017) and Tet1 deletion 
developmental phenotypes that might indirectly affect adult ISC function. To accomplish this, we 
generated a Tet1 inducible knockout (Tet1iKO) mouse model (Figure 1). The Tet1 inducible 
knockout is specific to the intestinal epithelium and induced by tamoxifen treatments (Kang et al. 
2015; el Marjou et al. 2004). Preliminary histological data on Tet1iKO mice revealed crypt 
hyperplasia, suggesting there was an increase in proliferation. Furthermore, ISCs isolated from 
control and Tet1iKO mice demonstrated a 4-fold increase in organoid forming ability (unpublished 
data). Together, these preliminary data lead us to hypothesize Tet1 negatively regulates self-
renewal in the adult intestine and may play a role in facilitating early differentiation. 
To test this hypothesis, we examined the effects of genetic ablation of Tet1 on ISC 
differentiation and proliferation by quantifying the number of EECs, tuft cells, ISCs, and 
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proliferating cells in Tet1iKO mice. In this study, we establish Tet1 contributes to ISC identity and 
fate, which represents a novel understanding of Tet1-mediated ISC regulation. The implications 
of our results will enhance our understanding of the functional significance of Tet1 in adult ISC 
biology to facilitate studies on intestinal damage and regeneration with applications to human 




The Tet1iKO mice were acquired with their Tet1 floxed alleles from La Jolla Institute for 
Allergy and Immunology (Kang et al. 2015) and crossed with vilCreER mice (el Marjou et al. 2004) 
to attain the desired genotype Tet1fl/fl:vilCreER+/-. The control mice did not have Tet1 floxed alleles 
but were heterozygous for vilCreER resulting in genotype Tet1+/+:vilCreER+/-. The Tet1 knockout 
uses a CRE protein with a villin promoter specific to the intestinal epithelium. To induce Tet1 
excision by cytoplasmic CRE, mice were injected with tamoxifen treatments. Subsequently, 
tamoxifen binds to the estrogen receptor on CRE to drive CRE into the nucleus to bind onto loxP 
sites in the genomic DNA and excise target Tet1 exons eight, nine, and ten (el Marjou et al. 2004). 
After excision, quantitative Polymerase Chain Reaction (qPCR) confirmed no Tet1 mRNA levels 
in the ISCs of Tet1iKO mice. Three Tet1iKO and three control mice were administered tamoxifen 
(10 mg/mL in 5% ethanol and 95% corn oil; Sigma) once a day for three days. Five days after the 
last dose of tamoxifen, the mice were administered EdU (5-Ethynyl-2′-deoxyuridine) via 
intraperitoneal injection to stain for cell proliferation. EdU is a thymine analog incorporated into 
DNA during S-phase of the cell cycle and detected using click chemistry (Lahann et al. 2009). 
Two hours after EdU injection, the mice were euthanized for tissue collection. 
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Figure 1. Tet1 inducible knockout mouse model. Tet1 exons eight, nine, and ten are floxed with 
two loxP sites where a specific order of nucleotides are arranged in the same direction. We can 
target Tet1 exclusively in the intestinal epithelium using a villin (vil) promoter for the CRE protein. 
CRE normally resides in the cytoplasm, but it contains an estrogen receptor (ER) that responds to 
tamoxifen and drives CRE into the nucleus where genomic DNA is found. There it binds to the 
loxP sites and removes the Tet1 exons. The control mice are not floxed but are heterozygous for 
vilCreER.   
 
Immunostaining quantification 
Enteroendocrine cells were marked by CHGA, tuft cells were marked by DCLK1, 
proliferating/ S-phase cells were marked by KI67/EdU, and intestinal stem cells (ISCs) were 
marked by OLFM4.  
For quantification of OLFM4 and KI67/EdU, images were taken as 1 µm optical sections 
using a Zeiss LSM 700 confocal microscope. OLFM4 + cells were quantified by the total number 
of positive cells. OLFM4 + maximum crypt position was measured based on the first cell position 
assigned at the base of each crypt as ‘0’. KI67 was quantified by counting all bisbenzimide-positive 
nuclei in each crypt and determining the percentage of KI67+ cells. Twelve crypts were quantified 
per mouse for OLFM4 and KI67/EdU. For quantification of CHGA and DCLK1 images were 
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taken on Olympus IX-81 fluorescence microscope and acquired through MetaMorph software. 
Staining was quantified by counting CHGA+ and DCLK1+ cell in each crypt and villus. Fifty villi 
and fifty crypts were quantified per mouse for CHGA and DCLK1. 40x magnification was used. 
Statistical significance was assessed by unpaired t-test in Prism 8 (GraphPad). 
Histology 
         For tissue preparation, intestinal resections from adult Tet1iKO and control mice (>8 wk 
of age) were separated into four intestinal segments (duodenum, jejunum, ileum, and colon) 
flushed with 1x phosphate-buffered saline (PBS) and placed in fresh 4% paraformaldehyde (PFA) 
overnight (14-18 hr.). The tissues were then removed from the 4% PFA and prepared for 
cryosectioning by immersion in 30% sucrose solution for at least 24 hrs at 4°C. The intestinal 
segments were then opened along the duodenal-ileal axis, embedded in optimal cutting 
temperature (OCT) medium, and frozen on dry ice. The OCT blocks were kept at −80°C until 
cryosectioning. Thin jejunum sections (8–10 μm) were cut on a cryostat and placed on positively 
charged microscope slides for staining and microscopy. 
Immunofluorescence 
         The tissue sections were rehydrated in PBS. To allow antibody binding, antigen retrieval 
was performed to undo the cross linking of proteins caused by the 4% PFA during tissue prep. 
Slides were placed in a decloaker solution and into a pressure cooker set for 30 minutes at 110°C. 
Slides were then incubated in PBS-0.3% Triton-X100 (Sigma) for 20 min at room temperature 
(21–25°C). The saline buffer was removed, and slides were incubated with 1X Animal-Free Block 
(Cell Signaling Technologies) for at least 20 min at room temperature. Primary antibodies (Table 
1) were diluted at specified concentrations in 1× Animal-Free Block and incubated overnight at 
4°C. Secondary antibodies were diluted 1:500 in 1× Animal-Free Block and incubated for 30 min 
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at room temperature. Nuclei were stained with bisbenzimide (Sigma) diluted 1:1000 in PBS and 
incubated for 20 min at room temperature. Hydromount was used to coverslip slides.    
Table 1. Primary and secondary antibodies.  





OLFM4 ISC Rabbit Yes 1:400 39141 Cell Signaling 
Technology 
KI67 Proliferating Rat Yes 1:400 350502 Biolegend 
DCLK1 Tuft  Rabbit Yes 1:100 ab37994 Abcam 
CHGA Enteroendocrine Rabbit Yes 1:200 20085 Immunostar 
Donkey anti-Rabbit 
IgG (H+L) Highly 
Cross-Adsorbed 
Secondary Antibody, 
Alexa Fluor Plus 555 




- Human - 1:500 151202 Biolegend 
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Figures:  
 
Figure 2. Average number of enteroendocrine cells per unit in Tet1iKO and control mice. (A) 
Average CHGA+ cells per crypt (n=3 biological replicates, 50 crypts per mouse). (B) Average 
CHGA+ cells per villus (*P<0.05; n=3 biological replicates, 50 villi per mouse). Data are 
mean±s.e.m. and individual points represent biological replicates. (*indicates significance, p < 
0.05; ** indicates significance, p ≤ 0.01, unpaired t-test).  
 
 
Figure 3. Average number of tuft cells per unit in Tet1iKO and control mice. (A) Average 
DCLK1+ cells per unit in crypt (*P<0.05; n=3 biological replicates, 50 crypts per mouse). (B) 
Average DCLK1+ cells per unit in villus (**P<0.01; n=3 biological replicates, 50 villus per 
mouse). Data are mean±s.e.m. and individual points represent biological replicates. (*indicates 
significance, p<0.05; ** indicates significance, p ≤ 0.01, unpaired t-test).  
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Figure 4. Average number of ISCs and maximum ISC crypt position in Tet1iKO and control mice 
with representative images. (A) OLFM4+ cells per crypt (*P<0.05; n=3 biological replicates, 12 
crypts per mouse). (B) Maximum OLFM4+ crypt position (*P<0.05; n=3 biological replicates, 12 
crypts per mouse). Data are mean±s.e.m. and individual points represent biological replicates. 
(*indicates significance, p<0.05; ** indicates significance, p ≤ 0.01, unpaired t-test). Inset from 
(Gracz et al. 2014). (C) Fluorescence microscopy reveals representative images of ISCs in the 
crypt of Tet1iKO and control mice. Scale bar: 25 µm. 
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Figure 5. Average percent S-phase and proliferating cells per unit in Tet1iKO and control mice. 
(A) Average percent EdU+ cells per crypt (n=3 biological replicates, 12 crypts per mouse). (B) 
Average percent KI67+ cells per crypt (n=3 biological replicates, 12 crypts per mouse). Data are 
mean±s.e.m. and individual points represent biological replicates (*indicates significance, p<0.05; 
** indicates significance, p ≤ 0.01, unpaired t-test). 
 
Results: 
Tet1iKO mice contained fewer enteroendocrine cells in the villus. 
Intestinal stem cells (ISCs) at the base of the intestinal crypts differentiate towards the 
villus tip into post-mitotic cell lineages, including enteroendocrine cells (EECs). EECs contain 
microvilli that face into the lumen and sense nutrients in the intestine. Additionally, they release 
hormones into the lamina propria. To understand the effects of chromatin-modifying enzyme 
TET1 on ISC differentiation, we quantified the average number of cells expressing an EEC marker 
(CHGA) in the crypt and villus after genetic ablation of Tet1. ISCs begin to differentiate into EECs 
starting from the crypts towards the villus tip, making it crucial to quantify the number of EECs in 
both the crypt and villus. In Tet1iKO mice, the average number of EECs per crypt was not 
significantly different compared to the control (Figure 2A). However, in the Tet1iKO mice there 
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was a significant decrease (p ≤ 0.05) in the average number of EECs per villus compared to the 
control (Figure 2B). Our results suggest Tet1 is involved in ISC differentiation into EECs. 
 
Tet1iKO mice contained fewer tuft cells in the villus and crypt. 
To further explore the effects of Tet1 on ISC differentiation, we proceeded to quantify a 
different cell lineage in the intestinal epithelium. The second ISC derived post-mitotic lineage we 
studied are tuft cells, which contain brush-like microvilli on their apical surface. Tuft cells respond 
to parasitic infections by releasing a proinflammatory cytokine, IL25 (von Moltke et al. 2016). To 
understand the role of Tet1 in ISC differentiation for tuft cells, we quantified the average number 
of cells expressing a tuft cell marker (DCLK1) in the crypt and villus after genetic ablation of Tet1. 
In Tet1iKO mice, there was a significant decrease (p ≤ 0.05) in the average number of tuft cells 
per crypt compared to the control (Figure 3A). Additionally, in the Tet1iKO mice there was a 
significant decrease (p ≤ 0.01) in the average number of tuft cells per villus compared to the 
control. Our results suggest Tet1 is also involved in ISC differentiation into tuft cells. 
 
Tet1iKO mice contained more intestinal stem cells and a higher maximum crypt position. 
Our results suggest Tet1 is involved in ISC differentiation for two post-mitotic cell lineages 
in the intestinal epithelium. Alternatively, to understand the role of Tet1 on self-renewal, we 
quantified the number of cells expressing an ISC marker (OLFM4) in the crypt after genetic 
ablation of Tet1. Quantification was restricted to the crypts because ISCs self-replicate in the 
crypts and are not present in the villi. In the Tet1iKO mice, there was a significant increase (p ≤ 
0.05) in the number of ISCs per crypt compared to the control (Figure 4A). To study differentiation 
delays, we measured the ISCs maximum crypt position. Our results reveal ISCs in Tet1iKO mice 
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extend further up the crypt compared to the control (p ≤ 0.05) (Figure 4B). Representative images 
of the OLFM4+ cells in the crypts of Tet1iKO mice show an increase in ISC numbers compared 
to the control (Figure 4C).  Furthermore, crypt position labeling reveals a greater maximum crypt 
position for the Tet1iKO mice at maximum crypt position 12 compared to the maximum crypt 
position 6 for the control (Figure 4C). Our results imply that Tet1 might be involved in regulating 
self-renewal and differentiation for ISCs.  
 
Intestinal stem cell proliferative potential was unchanged in Tet1iKO mice 
To account for the increase in ISCs present in Tet1iKO mice, we measured ISC 
proliferation rates in the crypts. With a confocal microscope, we quantified the percent of cells 
expressing a proliferation and S-phase marker (KI67+ and EdU+) in the crypts after genetic 
ablation of Tet1. In the Tet1iKO mice, the percent of proliferating and S-phase cells per crypt was 
not significantly different compared to the control (Figure 5A and 5B). Our results suggested Tet1 
was not involved in ISC proliferation. 
 
Discussion: 
In this study, we report that knocking out Tet1 in adult intestinal epithelium for five days 
results in a greater number of ISCs with no change to proliferation rates, as well as a reduction in 
EEC and tuft cell lineages. Our in-vivo studies revealed Tet1iKO mice demonstrate fewer average 
numbers of EECs in the villi but remain unchanged in the crypts compared to the control mice. 
The absence of significant change in the number of EECs present in the crypts can be attributed to 
the lack of specialized cells in the crypts, since EECs mostly reside in the villi. However, the results 
show a decreasing trend for the EECs in the crypts of Tet1iKO mice. Additionally, Tet1iKO mice 
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demonstrate fewer tuft cells in the villi and crypts compared to the control mice. The decrease in 
EECs and tuft cells in the intestine of Tet1iKO mice signifies Tet1 contributes to differentiation in 
the intestinal epithelium for EECs and tuft cell lineages. 
Tet1 null mice have been reported to present stunted intestinal length and a decrease in 
proliferating cell numbers in the postnatal intestine (Kim et al. 2016). Contrary to previous reports 
on Tet1 null mice, Tet1iKO mice present a greater number of ISCs compared to the control. The 
increase in ISCs could imply an increase in ISC proliferation, which would be consistent with our 
hypothesis that Tet1 negatively regulates self-renewal. However, our results revealed the percent 
of proliferating and S-phase cells in the crypts are unchanged between control and Tet1iKO mice. 
This finding was inconsistent with previous neuronal studies on adult Tet1 null mice, which have 
been shown to present defective self-renewal of neural progenitor cells (Rudenko et al. 2013; 
Zhang et al. 2013; Xin et al. 2015). Nonetheless, a higher number of ISCs with no change in 
proliferation suggest the ISCs in Tet1iKO mice are experiencing defects in differentiation and 
remain in a multipotent stem cell state for a longer time. Quantification of maximum ISC crypt 
position revealed ISCs from Tet1iKO mice are observed significantly further up the crypt-villus 
axis, further suggesting delayed differentiation. These results imply Tet1 is involved in facilitating 
proper ISC differentiation but does not regulate ISC proliferation. 
Previous experiments by our lab used control mouse genotype: Tet1 floxed (Tet1fl/fl) and 
vilCreER null (vilCreER-/-). However, loxP sites on floxed alleles have been shown to affect gene 
expression even if the vilCreER is not present to bind to the loxP sites and excise the target exons 
(Dorà et al.  2016). This study used control mice homozygous for wild type Tet1 alleles without 
loxP sites (Tet1+/+) and heterozygous for vilCre (vilCreER+/-). Tet1iKO mice show no significant 
difference in average number of EECs in the villus when using the Tet1fl/fl:vilCreER-/- control. 
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However, there was a significant decrease in Tet1KO mice when comparing to the 
Tet1+/+:vilCreER+/- control. As for tuft cells, there was a significant decrease in Tet1iKO mice when 
comparing both controls, but the Tet1+/+:vilCreER+/- control data had a smaller p value. These 
findings suggest loxP sites on floxed Tet1 exons were affecting gene expression for the control 
mice in our previous studies. 
Future experiments will use immunofluorescent staining on other differentiated cell types 
including Paneth cells, goblet cells, and enterocytes to confirm all secretory and absorptive 
intestinal epithelial cell lineages are affected by the loss of Tet1. Furthermore, to confirm the 
increased number of ISCs in Tet1iKO mice, future experiments will use a functional assay for 
stemness. Specifically, by prepping crypt enriched intestinal epithelial organoids from Tet1iKO 
and control mice, we would expect greater organoid formation from the Tet1iKO culture compared 
to the control due to the greater number of ISC in the Tet1iKO mice. Lastly, using intestinal 
organoids we can test differentiation defects and force specialized cell differentiation by 
incubating intestinal organoids with type 2 cytokine interleukin 13 to induce tuft cell 
differentiation (Gracz et al. 2018). 
Tet1-mediated conversion from 5mC to 5hmC has been established as an epigenetic 
mechanism involved in postnatal intestinal maturation required for ISC function (Kim et al. 2016). 
However, a definitive role in the intestine for Tet1 had not been previously established. Our 
findings demonstrate that Tet1 drives tuft and EEC specification but does not regulate self-renewal 
in the adult intestine. These findings implicate Tet1 is an important ISC regulator promoting 
differentiation with applications to furthering research on ISC studies for intestinal damage and 
regeneration. 
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